KIMBERLY EDWARDS: Open Payments
NPI 1740616010 · FORT THOMAS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 10 companies in 2025. Trend: 2023 $312 · 2024 $82 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| ABIOMED | 1 | $31 |
| Alkermes, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: FANAPT, ARISTADA, VRAYLAR, Jornay PM, FARXIGA, TZIELD, PAXLOVID, Ozempic.
Industry payments across KY — which companies pay providers there.
